Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-01-25FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for CLARITIN-D 12 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies [Phase 3]
Phase 3 clinical trial evaluating a nasal spray for perennial allergic rhinitis; results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis [Phase 3]
A Phase 3 clinical trial evaluating the safety and tolerability of a nasal spray for perennial allergic rhinitis has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS [Phase 4]
Phase 4 trial comparing patient experience and preference between fluticasone furoate nasal spray and fluticasone propionate nasal spray for…
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Herbal Treatment for Perennial Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluating a herbal treatment for perennial allergic rhinitis has completed. Results were posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Allex (desloratadine) — Schering-Plough Europe
Desloratadine product Allex (Schering-Plough Europe) has been withdrawn from the market.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial evaluating fluticasone furoate nasal spray for perennial allergic rhinitis completed, with study results posted in …
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis [Phase 4]
A Phase 4 trial evaluating fexofenadine for relief of perennial and intermittent allergic rhinitis in Filipino children has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis [Phase 4]
Phase 4 clinical trial evaluating the effect of levocetirizine on nasal nitric oxide and nasal eosinophils in adults with perennial allergic…
-
FDA approval · 2009-08-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a Supplemental Application for Singulair (montelukast sodium) submitted by Organon LLC. This action typically results in labeli…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)
Clinical trial updating pediatric response to desloratadine syrup for perennial allergic rhinitis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) [Phase 4]
Phase 4 trial evaluating the effects of mometasone furoate nasal spray in subjects with sleep-disordered breathing associated with perennial…
-
FDA approval · 2009-04-30FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for azelastine hydrochloride, a generic antihistamine product.
-
CLINICAL_TRIALS trial_result · 2009-04-27Clinical Trial Update: Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis [Phase 2]
A Phase 2 trial of an immunomodulatory therapy for adults with perennial allergic rhinitis and rhinoconjunctivitis due to house dust mite an…
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Children, Perennial Allergic Rhinitis (PAR), l-t Growth [Phase 4]
This is a completed Phase 4 clinical trial evaluating l-t Growth in children with perennial allergic rhinitis. The study was sponsored by As…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) [Phase 3]
Phase 3 trial evaluating desloratadine for intermittent allergic rhinitis completed with results posted in 2009.
-
FDA label_change · 2009-01-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application to update the labeling for Singulair (montelukast) under Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-01-06Clinical Trial Update: Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED) [Phase 4]
This is a termination update for a Phase 4 trial evaluating Nasonex (mometasone furoate) for sleep disturbances related to perennial allergi…
-
FDA approval · 2008-06-20FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's cetirizine hydrochloride under an original generic application, enabling a generic cetirizine hydrochlorid…
-
FDA approval · 2008-04-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy [Phase 1, Phase 2]
This update reports the completion of a Phase 1/2 study of a house dust mite allergen vaccine in patients with perennial allergic rhinitis a…
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC. The action updates labeling under NDA020829.
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial evaluating levocetirizine for nasal obstruction in perennial allergic rhinitis has completed.
-
FDA approval · 2007-11-21FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Omnaris (ciclesonide) submitted by Covis Pharma US, Inc., authorizing an update to the produ…
-
FDA approval · 2007-09-19FDA Approved: GOOD NEIGHBOR PHARMACY CHILDRENS LORATADINE — Supplemental Application (AmerisourceBergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Children's Loratadine (loratadine) sponsored by AmerisourceBergen.